nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Hydroxyurea—psoriasis	0.0623	0.179	CbGbCtD
Bepridil—CYP2D6—Cholecalciferol—psoriasis	0.0378	0.108	CbGbCtD
Bepridil—ABCB1—Mycophenolate mofetil—psoriasis	0.0348	0.0997	CbGbCtD
Bepridil—ABCB1—Betamethasone—psoriasis	0.0298	0.0855	CbGbCtD
Bepridil—ABCB1—Prednisolone—psoriasis	0.0294	0.0844	CbGbCtD
Bepridil—ABCB1—Hydrocortisone—psoriasis	0.0279	0.08	CbGbCtD
Bepridil—ABCB1—Prednisone—psoriasis	0.0278	0.0797	CbGbCtD
Bepridil—ABCB1—Cyclosporine—psoriasis	0.0263	0.0756	CbGbCtD
Bepridil—CYP2D6—Cyclosporine—psoriasis	0.0248	0.0712	CbGbCtD
Bepridil—ABCB1—Dexamethasone—psoriasis	0.0173	0.0498	CbGbCtD
Bepridil—CYP2D6—Dexamethasone—psoriasis	0.0163	0.0469	CbGbCtD
Bepridil—ABCB1—Methotrexate—psoriasis	0.0139	0.04	CbGbCtD
Bepridil—Dry mouth—Cyclosporine—psoriasis	0.000592	0.00131	CcSEcCtD
Bepridil—Myalgia—Mycophenolate mofetil—psoriasis	0.000591	0.00131	CcSEcCtD
Bepridil—Anxiety—Mycophenolate mofetil—psoriasis	0.000589	0.0013	CcSEcCtD
Bepridil—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000587	0.0013	CcSEcCtD
Bepridil—Diarrhoea—Hydroxyurea—psoriasis	0.000586	0.0013	CcSEcCtD
Bepridil—Vertigo—Prednisolone—psoriasis	0.000581	0.00129	CcSEcCtD
Bepridil—Oedema—Cyclosporine—psoriasis	0.00058	0.00128	CcSEcCtD
Bepridil—Syncope—Prednisolone—psoriasis	0.00058	0.00128	CcSEcCtD
Bepridil—Dry mouth—Mycophenolate mofetil—psoriasis	0.000578	0.00128	CcSEcCtD
Bepridil—Loss of consciousness—Prednisolone—psoriasis	0.000569	0.00126	CcSEcCtD
Bepridil—Vertigo—Hydrocortisone—psoriasis	0.000568	0.00126	CcSEcCtD
Bepridil—Abdominal pain—Mycophenolic acid—psoriasis	0.000567	0.00125	CcSEcCtD
Bepridil—Body temperature increased—Mycophenolic acid—psoriasis	0.000567	0.00125	CcSEcCtD
Bepridil—Syncope—Hydrocortisone—psoriasis	0.000567	0.00125	CcSEcCtD
Bepridil—Dizziness—Hydroxyurea—psoriasis	0.000566	0.00125	CcSEcCtD
Bepridil—Oedema—Mycophenolate mofetil—psoriasis	0.000566	0.00125	CcSEcCtD
Bepridil—Hyperhidrosis—Cyclosporine—psoriasis	0.000561	0.00124	CcSEcCtD
Bepridil—Hypertension—Prednisolone—psoriasis	0.000559	0.00124	CcSEcCtD
Bepridil—Shock—Mycophenolate mofetil—psoriasis	0.000557	0.00123	CcSEcCtD
Bepridil—Loss of consciousness—Hydrocortisone—psoriasis	0.000555	0.00123	CcSEcCtD
Bepridil—Arrhythmia—Dexamethasone—psoriasis	0.000554	0.00123	CcSEcCtD
Bepridil—Arrhythmia—Betamethasone—psoriasis	0.000554	0.00123	CcSEcCtD
Bepridil—Anorexia—Cyclosporine—psoriasis	0.000553	0.00122	CcSEcCtD
Bepridil—Bradycardia—Prednisone—psoriasis	0.00055	0.00122	CcSEcCtD
Bepridil—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000547	0.00121	CcSEcCtD
Bepridil—Hypertension—Hydrocortisone—psoriasis	0.000546	0.00121	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—psoriasis	0.000541	0.0012	CcSEcCtD
Bepridil—Rash—Hydroxyurea—psoriasis	0.00054	0.00119	CcSEcCtD
Bepridil—Anorexia—Mycophenolate mofetil—psoriasis	0.00054	0.00119	CcSEcCtD
Bepridil—Dermatitis—Hydroxyurea—psoriasis	0.00054	0.00119	CcSEcCtD
Bepridil—Myalgia—Hydrocortisone—psoriasis	0.000538	0.00119	CcSEcCtD
Bepridil—Headache—Hydroxyurea—psoriasis	0.000537	0.00119	CcSEcCtD
Bepridil—Anxiety—Hydrocortisone—psoriasis	0.000536	0.00119	CcSEcCtD
Bepridil—Vertigo—Triamcinolone—psoriasis	0.000535	0.00118	CcSEcCtD
Bepridil—Syncope—Triamcinolone—psoriasis	0.000534	0.00118	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000529	0.00117	CcSEcCtD
Bepridil—Oedema—Prednisolone—psoriasis	0.000528	0.00117	CcSEcCtD
Bepridil—Insomnia—Cyclosporine—psoriasis	0.000525	0.00116	CcSEcCtD
Bepridil—Loss of consciousness—Triamcinolone—psoriasis	0.000523	0.00116	CcSEcCtD
Bepridil—Paraesthesia—Cyclosporine—psoriasis	0.000521	0.00115	CcSEcCtD
Bepridil—Shock—Prednisolone—psoriasis	0.00052	0.00115	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—psoriasis	0.000519	0.00115	CcSEcCtD
Bepridil—Cough—Triamcinolone—psoriasis	0.000519	0.00115	CcSEcCtD
Bepridil—Dyspnoea—Cyclosporine—psoriasis	0.000517	0.00114	CcSEcCtD
Bepridil—Somnolence—Cyclosporine—psoriasis	0.000516	0.00114	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000516	0.00114	CcSEcCtD
Bepridil—Oedema—Hydrocortisone—psoriasis	0.000516	0.00114	CcSEcCtD
Bepridil—Asthenia—Mycophenolic acid—psoriasis	0.000515	0.00114	CcSEcCtD
Bepridil—Hypertension—Triamcinolone—psoriasis	0.000514	0.00114	CcSEcCtD
Bepridil—Insomnia—Mycophenolate mofetil—psoriasis	0.000512	0.00113	CcSEcCtD
Bepridil—Dyspepsia—Cyclosporine—psoriasis	0.000511	0.00113	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisolone—psoriasis	0.000511	0.00113	CcSEcCtD
Bepridil—Nausea—Hydroxyurea—psoriasis	0.000509	0.00112	CcSEcCtD
Bepridil—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000508	0.00112	CcSEcCtD
Bepridil—Shock—Hydrocortisone—psoriasis	0.000507	0.00112	CcSEcCtD
Bepridil—Myalgia—Triamcinolone—psoriasis	0.000507	0.00112	CcSEcCtD
Bepridil—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000505	0.00112	CcSEcCtD
Bepridil—Decreased appetite—Cyclosporine—psoriasis	0.000504	0.00112	CcSEcCtD
Bepridil—Somnolence—Mycophenolate mofetil—psoriasis	0.000503	0.00111	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—psoriasis	0.000503	0.00111	CcSEcCtD
Bepridil—Depression—Methotrexate—psoriasis	0.000501	0.00111	CcSEcCtD
Bepridil—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000501	0.00111	CcSEcCtD
Bepridil—Hyperhidrosis—Hydrocortisone—psoriasis	0.000499	0.0011	CcSEcCtD
Bepridil—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000498	0.0011	CcSEcCtD
Bepridil—Constipation—Cyclosporine—psoriasis	0.000496	0.0011	CcSEcCtD
Bepridil—Pain—Cyclosporine—psoriasis	0.000496	0.0011	CcSEcCtD
Bepridil—Dry mouth—Triamcinolone—psoriasis	0.000495	0.0011	CcSEcCtD
Bepridil—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000492	0.00109	CcSEcCtD
Bepridil—Anorexia—Hydrocortisone—psoriasis	0.000492	0.00109	CcSEcCtD
Bepridil—Diarrhoea—Mycophenolic acid—psoriasis	0.000491	0.00109	CcSEcCtD
Bepridil—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000489	0.00108	CcSEcCtD
Bepridil—Oedema—Triamcinolone—psoriasis	0.000486	0.00107	CcSEcCtD
Bepridil—Vertigo—Dexamethasone—psoriasis	0.000485	0.00107	CcSEcCtD
Bepridil—Vertigo—Betamethasone—psoriasis	0.000485	0.00107	CcSEcCtD
Bepridil—Syncope—Dexamethasone—psoriasis	0.000484	0.00107	CcSEcCtD
Bepridil—Syncope—Betamethasone—psoriasis	0.000484	0.00107	CcSEcCtD
Bepridil—Pain—Mycophenolate mofetil—psoriasis	0.000484	0.00107	CcSEcCtD
Bepridil—Constipation—Mycophenolate mofetil—psoriasis	0.000484	0.00107	CcSEcCtD
Bepridil—Arrhythmia—Prednisone—psoriasis	0.000483	0.00107	CcSEcCtD
Bepridil—Sweating—Methotrexate—psoriasis	0.000482	0.00107	CcSEcCtD
Bepridil—Shock—Triamcinolone—psoriasis	0.000478	0.00106	CcSEcCtD
Bepridil—Insomnia—Prednisolone—psoriasis	0.000478	0.00106	CcSEcCtD
Bepridil—Gastrointestinal pain—Cyclosporine—psoriasis	0.000475	0.00105	CcSEcCtD
Bepridil—Loss of consciousness—Betamethasone—psoriasis	0.000475	0.00105	CcSEcCtD
Bepridil—Loss of consciousness—Dexamethasone—psoriasis	0.000475	0.00105	CcSEcCtD
Bepridil—Dizziness—Mycophenolic acid—psoriasis	0.000474	0.00105	CcSEcCtD
Bepridil—Paraesthesia—Prednisolone—psoriasis	0.000474	0.00105	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00047	0.00104	CcSEcCtD
Bepridil—Hyperhidrosis—Triamcinolone—psoriasis	0.000469	0.00104	CcSEcCtD
Bepridil—Insomnia—Hydrocortisone—psoriasis	0.000466	0.00103	CcSEcCtD
Bepridil—Hypertension—Dexamethasone—psoriasis	0.000466	0.00103	CcSEcCtD
Bepridil—Hypertension—Betamethasone—psoriasis	0.000466	0.00103	CcSEcCtD
Bepridil—Paraesthesia—Hydrocortisone—psoriasis	0.000463	0.00102	CcSEcCtD
Bepridil—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000463	0.00102	CcSEcCtD
Bepridil—Myalgia—Betamethasone—psoriasis	0.00046	0.00102	CcSEcCtD
Bepridil—Myalgia—Dexamethasone—psoriasis	0.00046	0.00102	CcSEcCtD
Bepridil—Body temperature increased—Cyclosporine—psoriasis	0.000459	0.00101	CcSEcCtD
Bepridil—Abdominal pain—Cyclosporine—psoriasis	0.000459	0.00101	CcSEcCtD
Bepridil—Anxiety—Dexamethasone—psoriasis	0.000458	0.00101	CcSEcCtD
Bepridil—Anxiety—Betamethasone—psoriasis	0.000458	0.00101	CcSEcCtD
Bepridil—Dyspepsia—Hydrocortisone—psoriasis	0.000454	0.001	CcSEcCtD
Bepridil—Rash—Mycophenolic acid—psoriasis	0.000452	0.001	CcSEcCtD
Bepridil—Dermatitis—Mycophenolic acid—psoriasis	0.000452	0.000999	CcSEcCtD
Bepridil—Pain—Prednisolone—psoriasis	0.000452	0.000999	CcSEcCtD
Bepridil—Headache—Mycophenolic acid—psoriasis	0.000449	0.000994	CcSEcCtD
Bepridil—Decreased appetite—Hydrocortisone—psoriasis	0.000448	0.000991	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—psoriasis	0.000448	0.000991	CcSEcCtD
Bepridil—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000448	0.00099	CcSEcCtD
Bepridil—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000448	0.00099	CcSEcCtD
Bepridil—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000445	0.000985	CcSEcCtD
Bepridil—Vision blurred—Prednisone—psoriasis	0.000443	0.00098	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000442	0.000978	CcSEcCtD
Bepridil—Pain—Hydrocortisone—psoriasis	0.000441	0.000975	CcSEcCtD
Bepridil—Oedema—Betamethasone—psoriasis	0.000441	0.000974	CcSEcCtD
Bepridil—Oedema—Dexamethasone—psoriasis	0.000441	0.000974	CcSEcCtD
Bepridil—Insomnia—Triamcinolone—psoriasis	0.000439	0.000971	CcSEcCtD
Bepridil—Paraesthesia—Triamcinolone—psoriasis	0.000436	0.000964	CcSEcCtD
Bepridil—Shock—Betamethasone—psoriasis	0.000434	0.000959	CcSEcCtD
Bepridil—Shock—Dexamethasone—psoriasis	0.000434	0.000959	CcSEcCtD
Bepridil—Dyspnoea—Triamcinolone—psoriasis	0.000433	0.000957	CcSEcCtD
Bepridil—Dyspepsia—Triamcinolone—psoriasis	0.000427	0.000945	CcSEcCtD
Bepridil—Nausea—Mycophenolic acid—psoriasis	0.000426	0.000942	CcSEcCtD
Bepridil—Hyperhidrosis—Dexamethasone—psoriasis	0.000426	0.000942	CcSEcCtD
Bepridil—Hyperhidrosis—Betamethasone—psoriasis	0.000426	0.000942	CcSEcCtD
Bepridil—Vertigo—Prednisone—psoriasis	0.000422	0.000934	CcSEcCtD
Bepridil—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000422	0.000933	CcSEcCtD
Bepridil—Syncope—Prednisone—psoriasis	0.000422	0.000932	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—psoriasis	0.000421	0.000931	CcSEcCtD
Bepridil—Anorexia—Dexamethasone—psoriasis	0.00042	0.000929	CcSEcCtD
Bepridil—Anorexia—Betamethasone—psoriasis	0.00042	0.000929	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—psoriasis	0.000419	0.000926	CcSEcCtD
Bepridil—Asthenia—Cyclosporine—psoriasis	0.000416	0.000921	CcSEcCtD
Bepridil—Pain—Triamcinolone—psoriasis	0.000415	0.000918	CcSEcCtD
Bepridil—Loss of consciousness—Prednisone—psoriasis	0.000413	0.000914	CcSEcCtD
Bepridil—Abdominal pain—Hydrocortisone—psoriasis	0.000408	0.000901	CcSEcCtD
Bepridil—Body temperature increased—Hydrocortisone—psoriasis	0.000408	0.000901	CcSEcCtD
Bepridil—Asthenia—Mycophenolate mofetil—psoriasis	0.000406	0.000898	CcSEcCtD
Bepridil—Hypertension—Prednisone—psoriasis	0.000406	0.000898	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000401	0.000888	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000401	0.000888	CcSEcCtD
Bepridil—Myalgia—Prednisone—psoriasis	0.0004	0.000885	CcSEcCtD
Bepridil—Anxiety—Prednisone—psoriasis	0.000399	0.000882	CcSEcCtD
Bepridil—Insomnia—Betamethasone—psoriasis	0.000399	0.000881	CcSEcCtD
Bepridil—Insomnia—Dexamethasone—psoriasis	0.000399	0.000881	CcSEcCtD
Bepridil—Diarrhoea—Cyclosporine—psoriasis	0.000397	0.000878	CcSEcCtD
Bepridil—Paraesthesia—Betamethasone—psoriasis	0.000396	0.000875	CcSEcCtD
Bepridil—Paraesthesia—Dexamethasone—psoriasis	0.000396	0.000875	CcSEcCtD
Bepridil—Dyspepsia—Dexamethasone—psoriasis	0.000388	0.000858	CcSEcCtD
Bepridil—Dyspepsia—Betamethasone—psoriasis	0.000388	0.000858	CcSEcCtD
Bepridil—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000387	0.000856	CcSEcCtD
Bepridil—Body temperature increased—Triamcinolone—psoriasis	0.000384	0.000849	CcSEcCtD
Bepridil—Dizziness—Cyclosporine—psoriasis	0.000384	0.000849	CcSEcCtD
Bepridil—Oedema—Prednisone—psoriasis	0.000384	0.000848	CcSEcCtD
Bepridil—Decreased appetite—Dexamethasone—psoriasis	0.000383	0.000847	CcSEcCtD
Bepridil—Decreased appetite—Betamethasone—psoriasis	0.000383	0.000847	CcSEcCtD
Bepridil—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00038	0.000841	CcSEcCtD
Bepridil—Gastrointestinal disorder—Betamethasone—psoriasis	0.00038	0.000841	CcSEcCtD
Bepridil—Shock—Prednisone—psoriasis	0.000378	0.000835	CcSEcCtD
Bepridil—Pain—Dexamethasone—psoriasis	0.000377	0.000833	CcSEcCtD
Bepridil—Pain—Betamethasone—psoriasis	0.000377	0.000833	CcSEcCtD
Bepridil—Dizziness—Mycophenolate mofetil—psoriasis	0.000374	0.000828	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisone—psoriasis	0.000371	0.00082	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—psoriasis	0.00037	0.000819	CcSEcCtD
Bepridil—Asthenia—Hydrocortisone—psoriasis	0.00037	0.000818	CcSEcCtD
Bepridil—Rash—Cyclosporine—psoriasis	0.000366	0.000809	CcSEcCtD
Bepridil—Anorexia—Prednisone—psoriasis	0.000366	0.000809	CcSEcCtD
Bepridil—Dermatitis—Cyclosporine—psoriasis	0.000366	0.000808	CcSEcCtD
Bepridil—Headache—Cyclosporine—psoriasis	0.000364	0.000804	CcSEcCtD
Bepridil—Gastrointestinal pain—Dexamethasone—psoriasis	0.00036	0.000797	CcSEcCtD
Bepridil—Gastrointestinal pain—Betamethasone—psoriasis	0.00036	0.000797	CcSEcCtD
Bepridil—Rash—Mycophenolate mofetil—psoriasis	0.000357	0.000789	CcSEcCtD
Bepridil—Dermatitis—Mycophenolate mofetil—psoriasis	0.000357	0.000789	CcSEcCtD
Bepridil—Headache—Mycophenolate mofetil—psoriasis	0.000355	0.000784	CcSEcCtD
Bepridil—Vertigo—Methotrexate—psoriasis	0.000353	0.000781	CcSEcCtD
Bepridil—Diarrhoea—Hydrocortisone—psoriasis	0.000353	0.00078	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Prednisone—psoriasis	0.00035	0.000773	CcSEcCtD
Bepridil—Dizziness—Prednisolone—psoriasis	0.000349	0.000772	CcSEcCtD
Bepridil—Asthenia—Triamcinolone—psoriasis	0.000348	0.00077	CcSEcCtD
Bepridil—Body temperature increased—Betamethasone—psoriasis	0.000348	0.00077	CcSEcCtD
Bepridil—Body temperature increased—Dexamethasone—psoriasis	0.000348	0.00077	CcSEcCtD
Bepridil—Abdominal pain—Betamethasone—psoriasis	0.000348	0.00077	CcSEcCtD
Bepridil—Abdominal pain—Dexamethasone—psoriasis	0.000348	0.00077	CcSEcCtD
Bepridil—Insomnia—Prednisone—psoriasis	0.000347	0.000767	CcSEcCtD
Bepridil—Nausea—Cyclosporine—psoriasis	0.000345	0.000762	CcSEcCtD
Bepridil—Paraesthesia—Prednisone—psoriasis	0.000345	0.000762	CcSEcCtD
Bepridil—Cough—Methotrexate—psoriasis	0.000343	0.000758	CcSEcCtD
Bepridil—Dizziness—Hydrocortisone—psoriasis	0.000341	0.000754	CcSEcCtD
Bepridil—Dyspepsia—Prednisone—psoriasis	0.000338	0.000747	CcSEcCtD
Bepridil—Nausea—Mycophenolate mofetil—psoriasis	0.000336	0.000744	CcSEcCtD
Bepridil—Myalgia—Methotrexate—psoriasis	0.000335	0.00074	CcSEcCtD
Bepridil—Decreased appetite—Prednisone—psoriasis	0.000334	0.000738	CcSEcCtD
Bepridil—Rash—Prednisolone—psoriasis	0.000333	0.000736	CcSEcCtD
Bepridil—Dermatitis—Prednisolone—psoriasis	0.000333	0.000736	CcSEcCtD
Bepridil—Headache—Prednisolone—psoriasis	0.000331	0.000731	CcSEcCtD
Bepridil—Constipation—Prednisone—psoriasis	0.000328	0.000726	CcSEcCtD
Bepridil—Rash—Hydrocortisone—psoriasis	0.000325	0.000719	CcSEcCtD
Bepridil—Dermatitis—Hydrocortisone—psoriasis	0.000325	0.000718	CcSEcCtD
Bepridil—Headache—Hydrocortisone—psoriasis	0.000323	0.000714	CcSEcCtD
Bepridil—Dizziness—Triamcinolone—psoriasis	0.000321	0.00071	CcSEcCtD
Bepridil—Asthenia—Betamethasone—psoriasis	0.000316	0.000699	CcSEcCtD
Bepridil—Asthenia—Dexamethasone—psoriasis	0.000316	0.000699	CcSEcCtD
Bepridil—Gastrointestinal pain—Prednisone—psoriasis	0.000314	0.000694	CcSEcCtD
Bepridil—Nausea—Prednisolone—psoriasis	0.000314	0.000694	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—psoriasis	0.00031	0.000686	CcSEcCtD
Bepridil—Nausea—Hydrocortisone—psoriasis	0.000306	0.000677	CcSEcCtD
Bepridil—Rash—Triamcinolone—psoriasis	0.000306	0.000677	CcSEcCtD
Bepridil—Dermatitis—Triamcinolone—psoriasis	0.000306	0.000676	CcSEcCtD
Bepridil—Anorexia—Methotrexate—psoriasis	0.000306	0.000676	CcSEcCtD
Bepridil—Headache—Triamcinolone—psoriasis	0.000304	0.000673	CcSEcCtD
Bepridil—Body temperature increased—Prednisone—psoriasis	0.000303	0.000671	CcSEcCtD
Bepridil—Abdominal pain—Prednisone—psoriasis	0.000303	0.000671	CcSEcCtD
Bepridil—Diarrhoea—Betamethasone—psoriasis	0.000301	0.000667	CcSEcCtD
Bepridil—Diarrhoea—Dexamethasone—psoriasis	0.000301	0.000667	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000292	0.000646	CcSEcCtD
Bepridil—Dizziness—Betamethasone—psoriasis	0.000291	0.000644	CcSEcCtD
Bepridil—Dizziness—Dexamethasone—psoriasis	0.000291	0.000644	CcSEcCtD
Bepridil—Insomnia—Methotrexate—psoriasis	0.00029	0.000641	CcSEcCtD
Bepridil—Nausea—Triamcinolone—psoriasis	0.000288	0.000638	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—psoriasis	0.000288	0.000637	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—psoriasis	0.000286	0.000632	CcSEcCtD
Bepridil—Somnolence—Methotrexate—psoriasis	0.000285	0.00063	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—psoriasis	0.000282	0.000624	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—psoriasis	0.000279	0.000616	CcSEcCtD
Bepridil—Rash—Betamethasone—psoriasis	0.000278	0.000614	CcSEcCtD
Bepridil—Rash—Dexamethasone—psoriasis	0.000278	0.000614	CcSEcCtD
Bepridil—Dermatitis—Betamethasone—psoriasis	0.000278	0.000614	CcSEcCtD
Bepridil—Dermatitis—Dexamethasone—psoriasis	0.000278	0.000614	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—psoriasis	0.000277	0.000612	CcSEcCtD
Bepridil—Headache—Betamethasone—psoriasis	0.000276	0.00061	CcSEcCtD
Bepridil—Headache—Dexamethasone—psoriasis	0.000276	0.00061	CcSEcCtD
Bepridil—Asthenia—Prednisone—psoriasis	0.000275	0.000609	CcSEcCtD
Bepridil—Pain—Methotrexate—psoriasis	0.000274	0.000606	CcSEcCtD
Bepridil—Diarrhoea—Prednisone—psoriasis	0.000263	0.000581	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—psoriasis	0.000262	0.00058	CcSEcCtD
Bepridil—Nausea—Dexamethasone—psoriasis	0.000262	0.000579	CcSEcCtD
Bepridil—Nausea—Betamethasone—psoriasis	0.000262	0.000579	CcSEcCtD
Bepridil—Dizziness—Prednisone—psoriasis	0.000254	0.000561	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—psoriasis	0.000254	0.000561	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—psoriasis	0.000254	0.000561	CcSEcCtD
Bepridil—Rash—Prednisone—psoriasis	0.000242	0.000535	CcSEcCtD
Bepridil—Dermatitis—Prednisone—psoriasis	0.000242	0.000534	CcSEcCtD
Bepridil—Headache—Prednisone—psoriasis	0.00024	0.000532	CcSEcCtD
Bepridil—Asthenia—Methotrexate—psoriasis	0.00023	0.000509	CcSEcCtD
Bepridil—Nausea—Prednisone—psoriasis	0.000228	0.000504	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—psoriasis	0.000219	0.000485	CcSEcCtD
Bepridil—Dizziness—Methotrexate—psoriasis	0.000212	0.000469	CcSEcCtD
Bepridil—Rash—Methotrexate—psoriasis	0.000202	0.000447	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—psoriasis	0.000202	0.000447	CcSEcCtD
Bepridil—Headache—Methotrexate—psoriasis	0.000201	0.000444	CcSEcCtD
Bepridil—Nausea—Methotrexate—psoriasis	0.00019	0.000421	CcSEcCtD
Bepridil—CALM2—Signaling by ERBB2—IL6—psoriasis	5.59e-05	0.000281	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—IL6—psoriasis	5.59e-05	0.000281	CbGpPWpGaD
Bepridil—PDE1A—Immune System—JUN—psoriasis	5.59e-05	0.000281	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.58e-05	0.00028	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CRP—psoriasis	5.57e-05	0.00028	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CRP—psoriasis	5.57e-05	0.00028	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—IL6—psoriasis	5.57e-05	0.000279	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—IL6—psoriasis	5.57e-05	0.000279	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NFKBIA—psoriasis	5.45e-05	0.000274	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	5.41e-05	0.000272	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—IL6—psoriasis	5.41e-05	0.000272	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—IL6—psoriasis	5.41e-05	0.000272	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—IL6—psoriasis	5.4e-05	0.000271	CbGpPWpGaD
Bepridil—PDE1A—Immune System—NFKB1—psoriasis	5.38e-05	0.00027	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—IL6—psoriasis	5.36e-05	0.000269	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—LEP—psoriasis	5.35e-05	0.000269	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—APOE—psoriasis	5.35e-05	0.000269	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-E—psoriasis	5.32e-05	0.000267	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—IL6—psoriasis	5.32e-05	0.000267	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CARM1—psoriasis	5.31e-05	0.000267	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—IL6—psoriasis	5.3e-05	0.000266	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-DRB1—psoriasis	5.29e-05	0.000266	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—IL6—psoriasis	5.29e-05	0.000266	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—STAT3—psoriasis	5.28e-05	0.000265	CbGpPWpGaD
Bepridil—PDE1B—Disease—CD4—psoriasis	5.27e-05	0.000265	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—NFKBIA—psoriasis	5.25e-05	0.000264	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—IL6—psoriasis	5.24e-05	0.000263	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL20—psoriasis	5.22e-05	0.000262	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—IL6—psoriasis	5.19e-05	0.000261	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—IL6—psoriasis	5.19e-05	0.000261	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-E—psoriasis	5.15e-05	0.000259	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-E—psoriasis	5.15e-05	0.000259	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—IL6—psoriasis	5.14e-05	0.000258	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—IL6—psoriasis	5.14e-05	0.000258	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CARM1—psoriasis	5.14e-05	0.000258	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CARM1—psoriasis	5.14e-05	0.000258	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-DRB1—psoriasis	5.12e-05	0.000257	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-DRB1—psoriasis	5.12e-05	0.000257	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—IL6—psoriasis	5.12e-05	0.000257	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—IL6—psoriasis	5.12e-05	0.000257	CbGpPWpGaD
Bepridil—PDE1B—Immune System—JUN—psoriasis	5.11e-05	0.000257	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—STAT3—psoriasis	5.11e-05	0.000256	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—STAT3—psoriasis	5.11e-05	0.000256	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—ICAM1—psoriasis	5.08e-05	0.000255	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—NFKBIA—psoriasis	5.08e-05	0.000255	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—NFKBIA—psoriasis	5.08e-05	0.000255	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL20—psoriasis	5.05e-05	0.000254	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL20—psoriasis	5.05e-05	0.000254	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—NFKBIA—psoriasis	5.04e-05	0.000253	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PPARG—psoriasis	5.01e-05	0.000252	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NFKBIA—psoriasis	4.99e-05	0.00025	CbGpPWpGaD
Bepridil—PDE1B—Immune System—NFKB1—psoriasis	4.92e-05	0.000247	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ICAM1—psoriasis	4.92e-05	0.000247	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ICAM1—psoriasis	4.92e-05	0.000247	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NFKBIA—psoriasis	4.88e-05	0.000245	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NFKBIA—psoriasis	4.88e-05	0.000245	CbGpPWpGaD
Bepridil—PDE1A—Immune System—STAT3—psoriasis	4.84e-05	0.000243	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	4.79e-05	0.000241	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.78e-05	0.00024	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	4.64e-05	0.000233	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	4.64e-05	0.000233	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TYK2—psoriasis	4.47e-05	0.000224	CbGpPWpGaD
Bepridil—PDE1A—Disease—STAT3—psoriasis	4.47e-05	0.000224	CbGpPWpGaD
Bepridil—CALM3—Immune System—SOCS1—psoriasis	4.45e-05	0.000223	CbGpPWpGaD
Bepridil—PDE1B—Immune System—STAT3—psoriasis	4.42e-05	0.000222	CbGpPWpGaD
Bepridil—CALM1—Immune System—SOCS1—psoriasis	4.3e-05	0.000216	CbGpPWpGaD
Bepridil—CALM2—Immune System—SOCS1—psoriasis	4.3e-05	0.000216	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—TYK2—psoriasis	4.3e-05	0.000216	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.22e-05	0.000212	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—TYK2—psoriasis	4.16e-05	0.000209	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—TYK2—psoriasis	4.16e-05	0.000209	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TYK2—psoriasis	4.08e-05	0.000205	CbGpPWpGaD
Bepridil—PDE1B—Disease—STAT3—psoriasis	4.08e-05	0.000205	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CARM1—psoriasis	4.02e-05	0.000202	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD8A—psoriasis	3.94e-05	0.000198	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CD4—psoriasis	3.89e-05	0.000195	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CXCL8—psoriasis	3.89e-05	0.000195	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD8A—psoriasis	3.81e-05	0.000192	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD8A—psoriasis	3.81e-05	0.000192	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-B—psoriasis	3.79e-05	0.00019	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CARM1—psoriasis	3.79e-05	0.00019	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CD4—psoriasis	3.76e-05	0.000189	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CD4—psoriasis	3.76e-05	0.000189	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD4—psoriasis	3.73e-05	0.000188	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—psoriasis	3.7e-05	0.000186	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—psoriasis	3.69e-05	0.000185	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-B—psoriasis	3.67e-05	0.000184	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-B—psoriasis	3.67e-05	0.000184	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—JUN—psoriasis	3.61e-05	0.000181	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD4—psoriasis	3.61e-05	0.000181	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD4—psoriasis	3.61e-05	0.000181	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—psoriasis	3.57e-05	0.000179	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—psoriasis	3.57e-05	0.000179	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CXCL8—psoriasis	3.56e-05	0.000179	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-A—psoriasis	3.52e-05	0.000176	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—JUN—psoriasis	3.48e-05	0.000175	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NFKB1—psoriasis	3.48e-05	0.000175	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-A—psoriasis	3.4e-05	0.000171	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-A—psoriasis	3.4e-05	0.000171	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—psoriasis	3.38e-05	0.00017	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—psoriasis	3.38e-05	0.00017	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—VEGFA—psoriasis	3.38e-05	0.00017	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—JUN—psoriasis	3.37e-05	0.000169	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—JUN—psoriasis	3.37e-05	0.000169	CbGpPWpGaD
Bepridil—CALM3—Immune System—CRP—psoriasis	3.35e-05	0.000168	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—NFKB1—psoriasis	3.35e-05	0.000168	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—JUN—psoriasis	3.31e-05	0.000166	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—VEGFA—psoriasis	3.27e-05	0.000164	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—VEGFA—psoriasis	3.27e-05	0.000164	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CAT—psoriasis	3.27e-05	0.000164	CbGpPWpGaD
Bepridil—CALM3—Disease—HLA-A—psoriasis	3.25e-05	0.000163	CbGpPWpGaD
Bepridil—CALM2—Immune System—CRP—psoriasis	3.24e-05	0.000163	CbGpPWpGaD
Bepridil—CALM1—Immune System—CRP—psoriasis	3.24e-05	0.000163	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—NFKB1—psoriasis	3.24e-05	0.000163	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—NFKB1—psoriasis	3.24e-05	0.000163	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—NFKB1—psoriasis	3.22e-05	0.000162	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-DRB1—psoriasis	3.21e-05	0.000161	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NFKB1—psoriasis	3.18e-05	0.00016	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CAT—psoriasis	3.16e-05	0.000159	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CAT—psoriasis	3.16e-05	0.000159	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—psoriasis	3.16e-05	0.000159	CbGpPWpGaD
Bepridil—CALM2—Disease—HLA-A—psoriasis	3.14e-05	0.000158	CbGpPWpGaD
Bepridil—CALM1—Disease—HLA-A—psoriasis	3.14e-05	0.000158	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—STAT3—psoriasis	3.13e-05	0.000157	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—psoriasis	3.12e-05	0.000157	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NFKB1—psoriasis	3.11e-05	0.000156	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NFKB1—psoriasis	3.11e-05	0.000156	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-DRB1—psoriasis	3.11e-05	0.000156	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-DRB1—psoriasis	3.11e-05	0.000156	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—psoriasis	3.09e-05	0.000155	CbGpPWpGaD
Bepridil—CALM3—Immune System—ICAM1—psoriasis	3.08e-05	0.000155	CbGpPWpGaD
Bepridil—CALM3—Immune System—NFKBIA—psoriasis	3.06e-05	0.000154	CbGpPWpGaD
Bepridil—CALM3—Disease—APOE—psoriasis	3.03e-05	0.000152	CbGpPWpGaD
Bepridil—CALM1—Immune System—ICAM1—psoriasis	2.98e-05	0.00015	CbGpPWpGaD
Bepridil—CALM2—Immune System—ICAM1—psoriasis	2.98e-05	0.00015	CbGpPWpGaD
Bepridil—CALM2—Immune System—NFKBIA—psoriasis	2.96e-05	0.000149	CbGpPWpGaD
Bepridil—CALM1—Immune System—NFKBIA—psoriasis	2.96e-05	0.000149	CbGpPWpGaD
Bepridil—CALM2—Disease—APOE—psoriasis	2.93e-05	0.000147	CbGpPWpGaD
Bepridil—CALM1—Disease—APOE—psoriasis	2.93e-05	0.000147	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—psoriasis	2.89e-05	0.000145	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SOCS1—psoriasis	2.87e-05	0.000144	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—STAT3—psoriasis	2.86e-05	0.000144	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—psoriasis	2.85e-05	0.000143	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS2—psoriasis	2.82e-05	0.000142	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SOCS1—psoriasis	2.78e-05	0.00014	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SOCS1—psoriasis	2.78e-05	0.00014	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—TYK2—psoriasis	2.74e-05	0.000138	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS2—psoriasis	2.73e-05	0.000137	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS2—psoriasis	2.73e-05	0.000137	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—TYK2—psoriasis	2.65e-05	0.000133	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—TYK2—psoriasis	2.65e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—psoriasis	2.55e-05	0.000128	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOE—psoriasis	2.54e-05	0.000127	CbGpPWpGaD
Bepridil—CALM3—Immune System—TYK2—psoriasis	2.5e-05	0.000126	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAT—psoriasis	2.47e-05	0.000124	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—psoriasis	2.47e-05	0.000124	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—psoriasis	2.47e-05	0.000124	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOE—psoriasis	2.45e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOE—psoriasis	2.45e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Immune System—TYK2—psoriasis	2.42e-05	0.000122	CbGpPWpGaD
Bepridil—CALM1—Immune System—TYK2—psoriasis	2.42e-05	0.000122	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL8—psoriasis	2.39e-05	0.00012	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—psoriasis	2.39e-05	0.00012	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFNG—psoriasis	2.35e-05	0.000118	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAT—psoriasis	2.33e-05	0.000117	CbGpPWpGaD
Bepridil—CALM3—Disease—TYK2—psoriasis	2.31e-05	0.000116	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL8—psoriasis	2.31e-05	0.000116	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL8—psoriasis	2.31e-05	0.000116	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFNG—psoriasis	2.27e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFNG—psoriasis	2.27e-05	0.000114	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD4—psoriasis	2.27e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Disease—TYK2—psoriasis	2.24e-05	0.000112	CbGpPWpGaD
Bepridil—CALM2—Disease—TYK2—psoriasis	2.24e-05	0.000112	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—psoriasis	2.21e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD4—psoriasis	2.19e-05	0.00011	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD4—psoriasis	2.19e-05	0.00011	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—psoriasis	2.18e-05	0.00011	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—psoriasis	2.18e-05	0.00011	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—psoriasis	2.14e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—psoriasis	2.14e-05	0.000107	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOE—psoriasis	2.12e-05	0.000107	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—psoriasis	2.12e-05	0.000107	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—psoriasis	2.1e-05	0.000106	CbGpPWpGaD
Bepridil—CALM3—Disease—CD4—psoriasis	2.09e-05	0.000105	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—psoriasis	2.05e-05	0.000103	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOE—psoriasis	2.05e-05	0.000103	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—psoriasis	2.05e-05	0.000103	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOE—psoriasis	2.05e-05	0.000103	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—psoriasis	2.03e-05	0.000102	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—psoriasis	2.03e-05	0.000102	CbGpPWpGaD
Bepridil—CALM3—Immune System—JUN—psoriasis	2.03e-05	0.000102	CbGpPWpGaD
Bepridil—CALM1—Disease—CD4—psoriasis	2.02e-05	0.000102	CbGpPWpGaD
Bepridil—CALM2—Disease—CD4—psoriasis	2.02e-05	0.000102	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—psoriasis	2e-05	0.0001	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFKBIA—psoriasis	1.98e-05	9.93e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—JUN—psoriasis	1.96e-05	9.85e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—JUN—psoriasis	1.96e-05	9.85e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NFKB1—psoriasis	1.95e-05	9.8e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOE—psoriasis	1.92e-05	9.66e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFKBIA—psoriasis	1.91e-05	9.6e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFKBIA—psoriasis	1.91e-05	9.6e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NFKB1—psoriasis	1.89e-05	9.48e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NFKB1—psoriasis	1.89e-05	9.48e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOE—psoriasis	1.81e-05	9.1e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—psoriasis	1.75e-05	8.81e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—psoriasis	1.7e-05	8.52e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—psoriasis	1.7e-05	8.52e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—psoriasis	1.67e-05	8.41e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TYK2—psoriasis	1.62e-05	8.13e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—psoriasis	1.62e-05	8.13e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—psoriasis	1.58e-05	7.93e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TYK2—psoriasis	1.57e-05	7.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TYK2—psoriasis	1.57e-05	7.87e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—psoriasis	1.57e-05	7.86e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—psoriasis	1.57e-05	7.86e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—psoriasis	1.41e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—psoriasis	1.36e-05	6.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—psoriasis	1.36e-05	6.85e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—psoriasis	1.34e-05	6.73e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JUN—psoriasis	1.31e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—psoriasis	1.3e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—psoriasis	1.3e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JUN—psoriasis	1.27e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JUN—psoriasis	1.27e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFKB1—psoriasis	1.26e-05	6.34e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—psoriasis	1.22e-05	6.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFKB1—psoriasis	1.22e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFKB1—psoriasis	1.22e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—psoriasis	1.18e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—psoriasis	1.18e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—psoriasis	1.15e-05	5.75e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—psoriasis	1.13e-05	5.69e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—psoriasis	1.13e-05	5.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—psoriasis	1.11e-05	5.56e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—psoriasis	1.11e-05	5.56e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—psoriasis	1.1e-05	5.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—psoriasis	1.1e-05	5.51e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—psoriasis	1.09e-05	5.49e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—psoriasis	1.09e-05	5.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—psoriasis	8.65e-06	4.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—psoriasis	8.37e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—psoriasis	8.37e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—psoriasis	7.92e-06	3.98e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—psoriasis	7.66e-06	3.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—psoriasis	7.66e-06	3.85e-05	CbGpPWpGaD
